Pregnancy and Birth

 
Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose
October 09, 2024

Your daily dose of the clinical news you may have missed.

Better CV Health in Early Pregnancy Offsets High Genetic Risk: Daily Dose
September 27, 2024

Your daily dose of the clinical news you may have missed.

7 Drugs Approved for Primary Care: Q3 2024
September 26, 2024

Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.

Good Cardiovascular Health Early on May Offset Genetic Risk of Hypertensive Disorders of Pregnancy
September 17, 2024

New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.

CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose
September 06, 2024

Your daily dose of the clinical news you may have missed.

CPAP Therapy May Reduce Hypertensive Disorders of Pregnancy by More than 30%: Meta-Analysis
August 26, 2024

Obstructive sleep apnea during pregnancy increases risk for gestational hypertension and preeclampsia; CPAP therapy may lower risk significantly.

FDA Approves First Orally Disintegrating Tablet for Birth Control: Daily Dose
August 05, 2024

Your daily dose of the clinical news you may have missed.

Unplanned Pregnancy, Recent Relocation Among Top Barriers to Early Prenatal Care in US
July 31, 2024

Findings from a recent study highlight the need for targeted interventions to improve access to prenatal care for vulnerable populations.

Women's Health: Best and Worst States Ranked on 32 Measures of Access, Quality, Outcomes
July 31, 2024

Maternal mortality nearly doubled between 2018 and 2022 in the US. The Commonwealth Fund ranks states on how well they care for women.

FDA Approves Femlyv, First Orally Disintegrating Tablet for Birth Control
July 25, 2024

Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.